A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan
Condition(s):Relapsed or Refractory T-cell LymphomasLast Updated:March 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Relapsed or Refractory T-cell LymphomasLast Updated:March 20, 2024Recruiting
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:March 18, 2020Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:May 11, 2021Recruiting
Condition(s):Lymphoma, T-cell, Peripheral; Lymphoma, T-cell, CutaneousLast Updated:December 12, 2023Completed
Condition(s):Peripheral T-Cell LymphomaLast Updated:March 7, 2013Completed
Condition(s):Non-Hodgkin T-cell LymphomaLast Updated:September 9, 2020Completed
Condition(s):T Cell LymphomaLast Updated:August 13, 2020Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:May 12, 2020Unknown status
Condition(s):Peripheral T-cell LymphomaLast Updated:April 5, 2023Recruiting
Condition(s):Peripheral T-cell LymphomaLast Updated:February 11, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.